Large gap with delayed quotes
|
Last quote
12/15/2025
-
22:15:00
|
Bid
12/15/2025 -
21:59:59
|
Bid Volume |
Ask
12/15/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
48.50
-1.20
(
-2.41% )
|
48.53
|
10,500 |
48.59
|
1,400 |
Analysis date: 12.12.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 28.11.2025.
Interest
Strong
Strong
Three stars since 09.12.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.10.2025 at a price of 51.29.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 05.12.2025.
4wk Rel Perf
12.45%
12.45%
The four-week dividend-adjusted overperformance versus SP500 is 12.45%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 21.11.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.83%.
Mkt Cap in $bn
3.92
3.92
With a market capitalization between $2 & $8bn, HINGE HEALTH is considered a mid-cap stock.
G/PE Ratio
0.85
0.85
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
23.34
23.34
The estimated PE is for the year 2027.
LT Growth
19.79%
19.79%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
185
185
For 1% of index variation, the stock varies on average by 1.85%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
11.93
11.93
The value at risk is estimated at USD 11.93. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.10.2025
03.10.2025